Chlorpromazine versus lithium for people with schizophrenia

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of chlorpromazine alone versus lithium alone in the treatment of schizophrenia, schizophrenia‐like psychoses and schizoaffective psychoses. It is expected that the implementation of several subgroup analyses may be possible (see Subgroup analysis and investigation of heterogeneity).